SavedAdd your journal

Journals / Astım Allerji İmmünoloji / 2018 / Cilt: 16 - Sayı: 1

Urticaria and Angioedema due to Lercanidipine a Calcium Channel Blocker

Bir Kalsiyum Kanal Blokeri Olan Lerkanidipin Kullanımı Sonrası Akut Ürtiker ve Anjiyoödem

Derya ÜNAL
Mustafa DEMİRTÜRK
Sacide Rana IŞIK
Pages
57–59
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To our knowledge, this is the first case report suggesting a possible link between urticaria and angioedema and lercanidipine, a calcium channel blocker.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Antihypertensive medications such us angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, and calcium channel blockers may cause allergic reactions.
📊
Key Findings & Data:Urticaria and angioedema due to calcium channel blockers have been rarely reported.
💡
Conclusion & Impact:To our knowledge, this is the first case report suggesting a possible link between urticaria and angioedema and lercanidipine, a calcium channel blocker.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Antihypertensive medications such us angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, and calcium channel blockers may cause allergic reactions. Urticaria and angioedema due to calcium channel blockers have been rarely reported. To our knowledge, this is the first case report suggesting a possible link between urticaria and angioedema and lercanidipine, a calcium channel blocker.

Özet

Anjiyotensin dönüştürücü enzim (ACE) inhibitörleri, anjiyotensin reseptör blokerleri (ARB), beta-blokerler ve kalsiyum kanal blokerleri gibi çeşitli antihipertansif ilaçlar, allerjik reaksiyona neden olabilir. Kalsiyum kanal blokerlerine bağlı ürtiker ve anjiyoödem ise olgu sunumları halinde nadiren bildirilmektedir. Bu bildiride bir kalsiyum kanal blokeri olan lerkanidipin kullanımını takiben akut ürtiker ve anjiyoödem gelişen ilk olguyu sunmaktayız.

🔖

Cite This Article

ÜNAL, D., DEMİRTÜRK, M., IŞIK, S. R. (2018). Urticaria and Angioedema due to Lercanidipine a Calcium Channel Blocker. Astım Allerji İmmünoloji, Cilt: 16 - Sayı: 1, 57–59. https://ajindex.com/articles/143928

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Deacock SJ. An approach to the patient with urticaria. Clin Exp Immunol 2008;153:151-61
  2. Tan EK, Grattan CE. Drug-induced urticaria. Expert Opin Drug Saf 2004;3:471-84
  3. Fusade M. Drug-induced urticaria. Clin Rev Allergy Immunol 2006;30:19-23
  4. Gonzalez-Estrada A, Radojicic C. Penicillin allergy: A practical guide for clinicians. Cleve Clin J Med 2015;82:295-300
  5. Mali S. Anaphylaxis during the perioperative period. Anesth Essays Res 2012;6:124-33
  6. Borges MS, Fonseca FC, Hulett AC, Aveledo LG. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: An update. Pharmaceuticals 2010;3:10-8
  7. Piller LB, Ford CE, Davis BR, Nwachuku C, Black HR, Oparil S, et al; ALLHAT Collaborative Research Group. Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: A report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2006;8:649-56
  8. Upadhayai JB, Nangia AK, Mukhija RD, Misra M, Mohan L, Singh KK. Cutaneous reactions due to antihypertensive drugs. Indian J Dermatol 2006;51:189-91
  9. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al; ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013;68:702-12
  10. Messerli FH, Nussberg J. Vasopeptidase inhibition and angiooedema. Lancet 2000;356:608-9
  11. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: Current and future pharmacological targets. J Pharmacol Sci 2005;99:6-38
  12. Macaulay TE, Dunn SP. Cross-reactivity of ACE inhibitor- induced angioedema with ARBs. US Pharm 2007;32:HS17-23
  13. Haymore BR, Yoon J, Mikita CP, Klote MM, DeZee KJ. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated angiotensin-converting enzyme inhibitors: A meta-analysis. Ann Allergy Asthma Immunol 2008;101:495-9
  14. Southward J, Irvine E, Rabinovich M. Probable amlodipineinduced angioedema. Ann Pharmacother 2009;43:772-6.